Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

CUSIP: 87990A106

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
213,832,909
Total 13F shares
35,354,543
Share change
+996,186
Total reported value
$667,600,957
Price per share
$18.95
Number of holders
46
Value change
+$18,069,398
Number of buys
25
Number of sells
8

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 87990A106?
CUSIP 87990A106 identifies TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
2.4%
5,103,477
$102,065,000 30 Sep 2021
13F
Casdin Capital, LLC
13F
Company
1.7%
3,586,818
$74,068,000 30 Sep 2021
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.7%
3,551,508
$73,339,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.3%
2,773,109
$56,019,000 30 Sep 2021
13F
RTW INVESTMENTS, LP
13F
Company
1.1%
2,458,750
$48,581,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
0.76%
1,619,719
$33,448,000 30 Sep 2021
13F
Alphabet Inc.
13F
Company
0.43%
915,705
$18,909,000 30 Sep 2021
13F
Euclidean Capital LLC
13F
Company
0.43%
915,705
$18,909,000 30 Sep 2021
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.31%
673,270
$13,903,000 30 Sep 2021
13F
StepStone Group LP
13F
Company
0.22%
462,163
$10,681,000 30 Sep 2021
13F
Commodore Capital LP
13F
Company
0.24%
513,930
$10,613,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
0.24%
502,988
$10,386,000 30 Sep 2021
13F
Trustees of Columbia University in the City of New York
13F
Company
0.14%
291,828
$6,027,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.1%
215,963
$4,459,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.09%
182,337
$3,765,000 30 Sep 2021
13F
Woodline Partners LP
13F
Company
0.07%
150,080
$3,099,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.06%
123,290
$2,545,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
106,851
$2,206,000 30 Sep 2021
13F
Casdin Partners Master Fund, L.P.
3/4/5
10%+ Owner
class O/S missing
361,969
$1,541,988 03 Aug 2021
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.02%
50,000
$1,033,000 30 Sep 2021
13F
Jasper Ridge Partners, L.P.
13F
Company
0.02%
43,395
$896,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.02%
34,481
$712,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
34,211
$707,000 30 Sep 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.01%
30,308
$626,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.01%
20,435
$422,000 30 Sep 2021
13F
Ghisallo Capital Management LLC
13F
Company
0.01%
15,000
$310,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
0%
10,222
$211,000 30 Sep 2021
13F
Column Group LLC
13F
Company
4.4%
9,400,290
$194,116 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0%
8,016
$166,000 30 Sep 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
7,623
$157,000 30 Sep 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0%
7,526
$155,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0%
6,726
$139,000 30 Sep 2021
13F
SG Americas Securities, LLC
13F
Company
0%
6,237
$129,000 30 Sep 2021
13F
MetLife Investment Management, LLC
13F
Company
0%
5,857
$120,947 30 Sep 2021
13F
JeenJoo Kang
3/4/5
Director
class O/S missing
25,000
$106,500 03 Aug 2021
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0%
4,431
$91,500 30 Sep 2021
13F
STRS OHIO
13F
Company
0%
3,200
$66,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0%
3,056
$63,000 30 Sep 2021
13F
Pinz Capital Management, LP
13F
Company
0%
2,508
$52,000 30 Sep 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
2,400
$50,000 30 Sep 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,690
$35,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
0%
1,589
$33,000 30 Sep 2021
13F
Legal & General Group Plc
13F
Company
0%
1,305
$27,000 30 Sep 2021
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
1,068
$22,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,035
$21,000 30 Sep 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
479
$10,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0%
375
$8,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
77
$2,000 30 Sep 2021
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0%
26
$1,000 30 Sep 2021
13F

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) as of Q4 2021

As of 31 Dec 2021, Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,354,543 shares. The largest 10 holders included Column Group LLC, FMR LLC, Casdin Capital, LLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, BlackRock Inc., Alphabet Inc., Euclidean Capital LLC, and Deep Track Capital, LP. This page lists 46 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
44
Q4 2021 holders
46
Holder diff
2
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.